Lucknow, India

Anirudha Karvande



 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anirudha Karvande: Pioneer in Pharmaceutical Innovations

Introduction: Anirudha Karvande is an accomplished inventor based in Lucknow, India, known for his significant contributions in the field of pharmaceuticals. With a keen focus on bone health, Anirudha has developed innovative solutions aimed at combating the challenges related to bone tissue degeneration.

Latest Patents: Anirudha holds a notable patent for a "Pharmaceutical composition for the treatment of diminution of bone tissue." This invention delineates a method for the prevention and/or treatment of the reduction of bone tissue utilizing a composition that includes compounds such as Withaferin A (WFA), Withanolide A, and Withanone. The formulation has demonstrated enhanced bioavailability of WFA in rodents, showcasing its potential effectiveness as compared to regular WFA. Furthermore, it significantly promotes bone marrow cell differentiation and increases the ratio of bone volume to tissue volume (BV/TV %) by threefold, marking a substantial advancement in the field.

Career Highlights: Anirudha is currently employed at the Council of Scientific and Industrial Research, where he actively engages in groundbreaking research. His work has not only contributed to scientific understanding but has also the potential to revolutionize treatments for bone-related ailments.

Collaborations: Anirudha works alongside talented professionals such as Ritu Trivedi and Prabhat Ranjan Mishra. Together, they contribute to the innovative research paradigm at their institution, demonstrating the value of collaboration in scientific endeavors.

Conclusion: Anirudha Karvande's dedication to improving healthcare through his innovations in pharmaceuticals stands as a testament to his skills as an inventor. His patent for a novel pharmaceutical composition marks an important milestone in the treatment of bone tissue degeneration, promising improved outcomes for patients suffering from these conditions. As he continues his work at the Council of Scientific and Industrial Research, the future looks bright for further innovative advancements spearheaded by Anirudha.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…